Glass Jacobson Investment Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History

Glass Jacobson Investment Advisors’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$51.7K	Hold	1,000	–	–	0.02%	309
2025 Q4	$49.7K	Hold	1,000	–	–	0.02%	312
2025 Q3	$47.8K	Hold	1,000	–	–	0.02%	306
2025 Q2	$31.5K	Hold	1,000	–	–	0.01%	335
2025 Q1	$36.2K	Hold	1,000	–	–	0.01%	420
2024 Q4	$36.2K	Hold	1,000	–	–	0.01%	420
2024 Q3	$31.2K	Hold	1,000	–	–	0.01%	436
2024 Q2	$26.8K	Hold	1,000	–	–	0.01%	438
2024 Q1	$34.1K	Hold	1,000	–	–	0.01%	404
2023 Q4	$28.9K	Hold	1,000	–	–	0.01%	400
2023 Q3	$27.6K	Hold	1,000	–	–	0.01%	389
2023 Q2	$30.1K	Buy	+1,000	New	+$35K	0.01%	390
2022 Q4	$35.7K	Buy	+1,000	New	+$34.8K	0.02%	370

Other funds holding SUPN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Glass Jacobson Investment Advisors's SUPN Position: Q1 2026 in Review

Glass Jacobson Investment Advisors held its Supernus Pharmaceuticals (SUPN) position steady in Q1 2026 at 1,000 shares worth $51.7K. The position accounts for 0.02% of the portfolio, ranked #309.

Glass Jacobson Investment Advisors first reported a position in SUPN in Q4 2022 and has held it in 13 quarters since. 327 funds tracked by Wall St. Rank hold SUPN as of Q1 2026.

Glass Jacobson Investment Advisors held 1,000 shares of Supernus Pharmaceuticals worth $51.7K as of Q1 2026.
Glass Jacobson Investment Advisors left its Supernus Pharmaceuticals share count unchanged in Q1 2026.
Supernus Pharmaceuticals made up 0.02% of Glass Jacobson Investment Advisors's portfolio in Q1 2026, its #309 holding.
Glass Jacobson Investment Advisors first reported a position in Supernus Pharmaceuticals in Q4 2022 and has held it in 13 quarters since.
327 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2026.

Based on Glass Jacobson Investment Advisors's 13F filing for Q1 2026, filed 23 Apr 2026.